The Role Of Triamcinolone In Seroma Prevention In Extended Latissimus Dorsi Flap In Breast Reconstruction

Abstract

Abstract Background: Seroma remains a common complication of surgeries involving the extended latissimus dorsi flap (ELDF) for breast reconstruction. However, there are several methods that have been used to treat seroma. This study aims to evaluate the efficacy of topical administration of triamcinolone acetonide in reducing seroma incidence in breast reconstruction surgeries. Methods: Cross sectional study was conducted at Al-Mouwasat University Hospital in Damascus-Syria. Between 2022-2023 including patients who came to the breast unit clinic seeking for breast reconstruction. 20 patients were injected with triamcinolone acetonide 80 mg on the fifth and seventh day of the surgery through the drain tube in the donor site. And the drain was removed directly on the seventh day of surgery. Follow up continued till 3 month post operation to report the seroma cases and other complications. Results : Mean age was 47 years (range 30-60), mean body mass index (BMI) was 26 kg/m2, 11 flaps were for immediate reconstructions, and 9 cases were for delayed reconstruction. one case of seroma (n=1) 5% was reported , mastectomy flap necrosis was in 3 cases (15%), breast flap seroma was seen in just one case ( 5%) . Conclusion: triamcinolone acetonide is considered easy and not expensive method for preventing seroma, therefore we recommend the topical usage of triamcinolone acetonide for prevention of seroma at the donor site of extended latissimus dorsi flap. Trial registration: researchregistry9062